LC3A, not LC3B, was found to be frequently downregulated in various cancer cell lines, and gene silencing of LC3A could be explained by DNA methylation in esophageal squamous cell carcinoma and lung cancer [22, 27]. This evidence concerns the gene MAP1LC3A and lung cancer.